$IDXX

Goldman Sachs Sees a Shift in the Stock Market — and Names 2 Stocks to Buy Now

Goldman Sachs identifies long-term trends like AI, e-commerce, and pet ownership as drivers for stock performance. The firm highlights Idexx Laboratories (IDXX) and Zeta Global (ZETA) as stocks to buy, citing recurring revenue and growth potential. IDXX reported $1.22B in Q2 revenue, up 10% YoY, with a $740 price target. ZETA saw $443M in Q2 revenue, up 43% YoY, with a positive earnings beat.

Original reporting
Published Oct 22, 2026, 5:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 5:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Goldman Sachs Sees a Shift in the Stock Market — and Names 2 Stocks to Buy Now — source image
Decision brief

The 30-second read

$IDXXBullishLow
01

Why it matters

The article provides analyst buy recommendations but no new corporate events.

02

Market read

Analyst endorsements may generate modest buying pressure for the two highlighted stocks.

03

What to watch

Potential headwinds from slower overall economic growth could dampen discretionary veterinary spending.

Relevance 4/10Novelty 2/10Timing: none

Background

Goldman Sachs strategists discuss secular growth trends and spotlight two stocks they recommend buying.

Company-level read

Ticker impact

$IDXXBullishMedium confidence
Context

Goldman Sachs analyst recommends a Buy on Idexx Laboratories, citing recurring revenue growth and upcoming product launches.

Expected impact

potential upward pressure as investors price in the positive analyst outlook

Evidence & confidence

The recommendation is based on recent earnings beat and growth prospects, but the earnings data are already public, limiting the catalyst strength.

$ZETABullishMedium confidence
Context

Goldman Sachs analyst recommends Zeta Global, highlighting AI‑driven marketing platform growth and strong recurring revenue.

Expected impact

likely slight upside as the market digests the buy rating

Evidence & confidence

The buy call rests on already‑released Q2 results, so the news adds limited new information.

Market effects

Highlights continued investor interest in AI‑enabled veterinary diagnostics and marketing technology.

U.S. equities may see modest sector‑level uplift in healthcare diagnostics and ad‑tech stocks.

Limited; the story is U.S.‑focused and does not affect broader macro trends.

Counterpoint

Given the earnings data are already priced in, the buy calls may be overstated.

Key entities

  • Goldman Sachs

    U.S. investment bank providing the analyst recommendations.

Related articles

$ZETAHigh

Goldman sees 41% upside in overlooked AI stock

Goldman Sachs upgraded Zeta Global (ZETA) to Buy with a $45 price target, citing 41% upside. The firm expects Zeta to benefit from corporate AI spending shifts and partnerships with Palantir (PLTR), OpenAI, and Snowflake (SNOW). Zeta reported Q2 revenue of $443M, up 44% YoY, and raised its full-year revenue outlook to $1.811B-$1.824B. Goldman projects higher revenue and EBIT than consensus for 2027.

$ZETAMed

Zeta Global Stock Rises as Goldman Lifts Target to $45

Zeta Global Holdings (ZETA) stock rose 5.07% premarket after Goldman Sachs upgraded it to Buy and raised its price target to $45 from $30. Analyst Callie Valenti cited the shift to unified marketing platforms and rising AI budgets as tailwinds. The upgrade follows similar moves from other analysts after Zeta's event showcasing new AI initiatives and a partnership with Palantir (PLTR).

$ZETAHigh

Why is Zeta Global stock surging today?

Zeta Global (ZETA) stock rose 6.5% in pre-market trading after Goldman Sachs upgraded it to Buy, raising its price target to $45 from $30. The firm cited a shift toward unified marketing platforms and rising AI investment as tailwinds. Other analysts also raised targets following the company's Zeta Live 2026 event, where it unveiled new AI products and partnerships. The S&P 500 and Dow Jones gained 0.2%, while the Nasdaq fell 0.1%.